首页> 外文OA文献 >PCV15 COMBINED OPTIMAL LIPID VALUE GOAL ATTAINMENT AFTER TREATMENT INITIATION WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS EZETIMIBE PLUS SIMVASTATIN COMBINATION THERAPY IN A MANAGED CARE PATIENT POPULATION WITH PRIOR CARDIOVASCULAR DISEASE IN THE UNITED STATES

【2h】

PCV15 COMBINED OPTIMAL LIPID VALUE GOAL ATTAINMENT AFTER TREATMENT INITIATION WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS EZETIMIBE PLUS SIMVASTATIN COMBINATION THERAPY IN A MANAGED CARE PATIENT POPULATION WITH PRIOR CARDIOVASCULAR DISEASE IN THE UNITED STATES

机译：伴有先发性冠心病的经治疗的护理患者中，使用辛伐他汀加烟酸延长释放联合治疗对结直肠病加辛伐他汀联合治疗后开始治疗后，PCV15合并最佳脂质价值目标治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Balu S; Quimbo RA; Rodgers K; Simko RJ; Cziraky MJ;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. [J] . Friedman HS, Rajagopalan S, Barnes JP, Clinical therapeutics . 2011,第2期

机译：依泽替米贝/辛伐他汀与他汀单药联合治疗可降低低密度脂蛋白胆固醇，并在现实世界中实现目标。
2. Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study [J] . William Insull Jr. Jan N. Basile Anthony N. Vo Ping Jiang MS Roopal Thakkar Robert J. Pad ley Journal of clinical lipidology . 2009,第2期

机译：烟酸血脂异常患者联合烟酸缓释和辛伐他汀与阿托伐他汀联合治疗的疗效和安全性：SUPREME研究
3. Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study [J] . William Insull Jr. Jan N. Basile Anthony N. Vo Ping Jiang MS Roopal Thakkar Robert J. Pad ley Journal of clinical lipidology . 2009,第2期

机译：烟酸血脂异常患者联合烟酸缓释和辛伐他汀与阿托伐他汀联合治疗的疗效和安全性：SUPREME研究
4. Exploration of a combination Phytosterol and Ezetimibe therapy for the treatment of combined dyslipidemia in a Syrian golden hamster model. [D] . Griffin, John D. 2012

机译：探索植物甾醇和依泽替米贝的组合疗法在叙利亚金仓鼠模型中治疗合并的血脂异常。
5. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease [O] . Ngoc‐Anh Le, Joanne E. Tomassini, Andrew M. Tershakovec, 2015

机译：从他汀类单一疗法转为依泽替米贝/辛伐他汀联合疗法与其他强化降脂策略相比对有症状心血管疾病的糖尿病患者脂蛋白亚类的影响
6. PCV9 CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATION'S PERSPECTIVE IN THE UNITED STATES [O] . Balu S, Quimbo RA, Simko RJ, 2009

机译：美国管理型组织对辛伐他汀加烟酸延长释放联合治疗与一般辛伐他汀治疗后PCV9心血管事件的减少
7. Studies of Ocular Complications of AIDS (SOCA): Database Documentation for'Combination Foscarnet and Ganciclovir Therapy versus Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS (CRRT)' [R] . 1997

机译：艾滋病眼部并发症（sOCa）研究：“联合膦甲酸和更昔洛韦治疗与单药治疗艾滋病患者复发性巨细胞病毒性视网膜炎（CRRT）”的数据库文件

PCV15 COMBINED OPTIMAL LIPID VALUE GOAL ATTAINMENT AFTER TREATMENT INITIATION WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS EZETIMIBE PLUS SIMVASTATIN COMBINATION THERAPY IN A MANAGED CARE PATIENT POPULATION WITH PRIOR CARDIOVASCULAR DISEASE IN THE UNITED STATES

著录项

引文网络

相似文献

相关主题

期刊订阅